Potassium

Potassium

SCHEMBL7344845

C[SiH](C)C.[K]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29016 0.89
Charcoal, Activated SCHEMBL7199313 0.80
SCHEMBL2798309 0.80
SCHEMBL2798311 0.80
SCHEMBL9223832 0.80
Fluoride SCHEMBL2648816 0.80
Hydrochloric Acid SCHEMBL8386129 0.80
SCHEMBL8967414 0.80
Hydrogen Sulfide SCHEMBL11460325 0.80
Helium SCHEMBL20953787 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 93 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101263257-B Method for attachment of silicon-containing compounds to a surface and for the synthesis of hypervalent silicon compounds ALEXIUM LTD 2013-03-27 CN claimed
CN-101263257-A Method for attachment of silicon-containing compounds to a surface and for the synthesis of hypervalent silicon compounds ALEXIUM LTD (CY) 2008-09-10 CN claimed
WO-2025003769-A2 AROMATIC HETEROCYCLIC PYRROLIDONE DERIVATIVE AND USE THEREOF 杭州百新生物医药科技有限公司 2025-01-02 WO disclosed
CN-111377822-B Preparation method of vilanaflo 天津药业研究院股份有限公司 2023-09-08 CN disclosed
CN-114031551-B Fluopicolide and synthesis method thereof 利民化学有限责任公司 2023-07-25 CN disclosed
CN-116322696-A Heterocyclic compounds as receptor 2-triggering agonists expressed on myeloid cells and methods of use 安进公司 2023-06-23 CN disclosed
EP-3286172-A1 LSD1 INHIBITORS AND USES THEREOF Constellation Pharmaceuticals, Inc. (US) 2018-02-28 EP disclosed
CN-107405337-A Substituted chroman and application method 艾伯维公司 2017-11-28 CN disclosed
WO-2016172496-A1 LSD1 INHIBITORS AND USES THEREOF CONSTELLATION PHARMACEUTICALS, INC. (US) 2016-10-27 WO disclosed
CN-102421828-B Continuous process for polymerization and emulsification of siloxane DOW CORNING 2014-12-10 CN disclosed
CN-104203928-A Triazinone compound and T-type calcium channel inhibitor NISSAN CHEMICAL IND LTD 2014-12-10 CN disclosed
CN-1312805-A Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake SEARLE & CO (US) 2001-09-12 CN disclosed
CN-1279669-A Aromatic sulfone hydroxamic acid metalloprotease inhibitors SEARLE & CO (US) 2001-01-10 CN disclosed
CN-1256285-A Polymerization catalyst and polymerization method DOW CORNING INC (US) 2000-06-14 CN disclosed
CN-1256283-A Method for polymerization of siloxanes DOW CORNING INC (US) 2000-06-14 CN disclosed
CN-1255161-A Protease inhibitors SMITHKINE BEECHAM CORP (US) 2000-05-31 CN disclosed
CN-1254337-A N-hydroxy 4-sulfonylbutyramide compounds MONSANTO CO (US) 2000-05-24 CN disclosed
CN-1253559-A Sulfonyl divalent aryl alpha-hydroxamic acid compounds MONSANTO CO (US) 2000-05-17 CN disclosed
WO-1996031476-A1 AROMATIC HYDROXYETHERS RHONE-POULENC RORER LIMITED (GB) 1996-10-10 WO disclosed
CN-1128269-A Oligoribonucleotides with amide backbone HOFFMANN LA ROCHE (CH) 1996-08-07 CN disclosed